Soo Chin Chan Malaysia

Assoc. Prof. Dr. Chan Soo Chin is an Associate Professor and Consultant Rehabilitation Physician at Universiti Malaya, with clinical and research interests in pulmonary, stroke and neurological rehabilitation. She is currently pursuing a PhD in Global Health at the University of Edinburgh, focusing on pulmonary rehabilitation service delivery and implementation in Malaysia. She is actively involved in pulmonary rehabilitation research and capacity-building across Asia, particularly in low- and middle-income settings, including a multicountry trial involving Bangladesh, India and Malaysia. She is also actively involved in regional and international education and collaborative initiatives aimed at improving access to and delivery of pulmonary rehabilitation.
Job Title
Associate Professor
Faculty / Department / Division
Department of Rehabilitation Medicine
Institution / Organisation
Universiti Malaya

22 November 2026, Sunday

Time Session
12:00
13:00
Azza Omar Chairperson Malaysia
  • Naoya Tanabe Speaker Japan
    Sarcopenia is an important extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD), contributing to reduced physical function and adverse clinical outcomes. Updated Asian Working Group for Sarcopenia (AWGS) 2025 criteria provide a framework for its assessment. Chest computed tomography (CT) enables evaluation of skeletal muscle quantity and quality, offering additional prognostic information. Particularly, reduced erector spinae muscle density, reflecting intramuscular fat accumulation, is associated with loss of health-related independence, in patients with normal body weight. Recent studies have also demonstrated an association between airway mucus plugging and sarcopenia in COPD. Greater mucus plug burden is associated with reduced exercise capacity, skeletal muscle mass, and fat mass, suggesting potential interactions between pulmonary and systemic impairment. These findings highlight the importance of comprehensive assessment beyond airflow limitation. Early identification of sarcopenia and integrated interventions targeting physical activity, nutrition, and respiratory health may improve long-term outcomes in COPD.
  • Pui Ching Shirley Ngai Speaker Hong Kong
    Chronic obstructive pulmonary disease (COPD) is frequently complicated by sarcopenia, a debilitating condition characterized by the accelerated loss of skeletal muscle mass and functional capacity. Compared with their healthy counterparts, individuals with COPD have a higher prevalence of developing sarcopenia. This disproportionate burden is driven by distinct, disease-specific biological mechanisms. Notably, COPD induces a structural muscle fiber shift from fatigue-resistant oxidative fibers (Type I) to force-predominant glycolytic fibers (Type II). This metabolic shift is fundamentally compounded by decreased capillarization and prominent intramuscular fat infiltration, which collectively compromise oxidative capacity and accelerate functional decline. Previous studies suggest that targeted nutritional intervention is critical in managing this complex phenotype, yet standard dietary guidelines routinely fall short. This presentation summarises the clinical recommendations and discusses how the nutritional supplementation would help and support the management for people with COPD.
  • Soo Chin Chan Speaker Malaysia
    This presentation explores sarcopenia in COPD from a rehabilitation perspective, focusing on how COPD affects skeletal muscle and how exercise training can modify these changes. It highlights the complementary roles of resistance and endurance training, before considering how pulmonary rehabilitation translates physiological improvements into better function and participation. The key message is that exercise targets the muscle, while rehabilitation helps translate these gains into what matters to the patient.
  • Q&A
Ballroom 3, Lower Ground Floor